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Introduction
Mutations in genes encoding chromatin remodeling factors have 
emerged as a major cause of neurodevelopmental disorders (1). The 
mechanisms employed by these factors to ensure precise regula-
tion of developmental gene expression remain largely unexplored. 
Furthermore, the neuroanatomical abnormalities that result from 
these mutations and the behavioral and psychiatric features asso-
ciated with specific brain defects remain unidentified for most of 
these conditions. Chromodomain–helicase–DNA-binding (CHD) 
proteins are ATP-dependent chromatin remodeling factors that 
use ATP to catalyze nucleosome translocation along chromatin, 
presumably to modulate access of transcriptional regulators (2). 
Mutations in CHD7 cause CHARGE syndrome, a complex devel-
opmental syndrome defined by a constellation of birth defects, 
which include coloboma, heart defects, atresia of the choanae, 
retarded growth and development, and genital and ear abnormal-
ities (3–5). Although neurodevelopmental abnormalities are not 
considered for clinical diagnosis, 99% of patients exhibit develop-
mental delay and 74% suffer from intellectual disability (6). The 
alterations in chromatin and brain structure that underlie these 
deficits have not been identified.
ChIP sequencing (ChIP-Seq) experiments in a variety of cell 
lines have identified widespread CHD7 recruitment across the 
genome (7–9). CHD7 appears to localize primarily to distal regu-
latory elements marked by lysine 4 monomethylation on histone 
3 (H3K4me1). In vitro nucleosome remodeling assays have con-
firmed the ability of CHD7 to translocate nucleosomes along a chro-
matin template and demonstrated a loss or reduction in this activity 
in CHARGE syndrome–associated CHD7 mutants (10). These find-
ings point to chromatin remodeling defects as a central pathogenic 
mechanism in CHARGE syndrome. However, whether this holds 
true in vivo and the effect of such changes on developmental gene 
expression have not been investigated.
As a first step toward identifying the neuroanatomical alter-
ations that may underlie the neurological deficits in CHARGE 
syndrome, we recently reported cerebellar hypoplasia in 35% 
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in neural stem and progenitor cells, but its role in neurogenesis during brain development remains unknown. Here we have 
shown that deletion of Chd7 from cerebellar granule cell progenitors (GCps) results in reduced GCp proliferation, cerebellar 
hypoplasia, developmental delay, and motor deficits in mice. Genome-wide expression profiling revealed downregulated 
expression of the gene encoding the glycoprotein reelin (Reln) in Chd7-deficient GCps. Recessive RELN mutations have been 
associated with severe cerebellar hypoplasia in humans. We found molecular and genetic evidence that reductions in Reln 
expression contribute to GCp proliferative defects and cerebellar hypoplasia in GCp-specific Chd7 mouse mutants. Finally, we 
showed that CHD7 is necessary for maintaining an open, accessible chromatin state at the Reln locus. Taken together, this 
study shows that Reln gene expression is regulated by chromatin remodeling, identifies CHD7 as a previously unrecognized 
upstream regulator of Reln, and provides direct in vivo evidence that a mammalian CHD protein can control brain development 
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of patients with CHD7 mutations (11). It 
remains unknown to what extent cerebellar 
defects contribute to the developmental delay 
and intellectual disability associated with 
CHARGE syndrome.
The cerebellum develops over several 
weeks in mice and several months in humans. 
The cerebellar territory is established during 
early embryogenesis by the action of secreted 
signaling molecules from a secondary orga-
nizer located at the mid-hindbrain boundary 
(reviewed in ref. 12). We previously reported 
that biallelic expression of Chd7 was essen-
tial for maintaining appropriate levels of Fgf8 
expression at this early stage of cerebellar 
development (11). As deregulated Fgf8 expres-
sion and signaling from this embryonic organiz-
er selectively disrupt the formation of the cer-
ebellar vermis, these findings identified a role 
for CHD7 in early embryonic cerebellar devel-
opment (13, 14). Toward the end of embryogen-
esis, the cerebellum initiates a period of rapid 
growth, primarily driven by the proliferation of 
granule cell progenitors (GCps) in the external 
granule layer (EGL) on the surface of the cer-
ebellar anlage. The primary mitogen driving 
GCp proliferation is Sonic Hedgehog (SHH), 
which is produced by postmigratory Purkinje 
cells (PCs) that become organized in a layer 
beneath the EGL during late embryonic stages 
(15–17). This process is associated with the for-
mation of cerebellar folia. Intriguingly, we have 
also detected cerebellar foliation anomalies in 
CHARGE syndrome patients (11), implying a 
role for CHD7 in GCp development.
Several genes associated with cerebellar 
hypoplasia, developmental delay, ataxia, and 
intellectual disability in humans are expressed 
in cerebellar GCps (reviewed in ref. 18). Homo-
zygous mutations in RELN, which encodes 
the secreted glycoprotein reelin, or the gene 
encoding its receptor VLDLR are responsible 
for severe cerebellar hypoplasia and intellec-
tual disability in humans (19, 20). Studies in 
mouse models have localized Reln expression 
to GCps and have reported essential roles for 
RELN signaling in PC migration, maturation, 
and GCp proliferation (21–23). RELN has also 
been associated with psychiatric disease in 
several contexts. For example, RELN expres-
sion has been reported to be reduced in post-
natal cerebella from autism patients (24, 25).
In this article, we report a role for CHD7 in 
controlling GCp proliferation and survival, and 
a striking downregulation of Reln gene expres-
sion in Chd7-deficient GCps. Increasing Reln 
expression partially rescued GCp proliferation 
Figure 1. Chd7 deletion from embryonic neural progenitors causes cerebellar hypoplasia and 
foliation abnormalities. (A–D) In situ hybridization for Chd7 exon 3 transcripts (blue) in sagittal 
sections through P0 Chd7fl/fl (control [cn]) and nestin-Cre Chd7fl/fl (cko) brains. Sections through 
the cerebellar vermis (A and B) and hemispheres (C and D) are shown. Note Chd7 expression in the 
olfactory bulb (OB), neocortex (NC), thalamus (Th), hypothalamus (Hy), hippocampus (HC), ven-
tricular zone (VZ), rostral migratory stream (RMS), and cerebellum (Cb) in cn sections (A and C), 
absent in the cko (B and D). (E and F) Whole-mount images (anterior to the top) with cerebellum 
outlined. (G and H) High-power images with cerebella outlined. SC, superior colliculus; IC, inferior 
colliculus. (I–N) Cresyl violet–stained sagittal sections through the cerebellum, anterior to the left, 
with vermis folia labeled with Roman numerals according to Inouye and Oda (77). The simplex 
(S), Crus I (CI), Crus II (CII), paramedian (PM), and pyramidis (P) folia are labeled in hemisphere 
sections. Note cerebellar hypoplasia (J and L) and disorganized folia in cko hemispheres (L, boxed 
area). Note the expansion of lobules IV–V and IX from vermis into the hemispheres (L, red text). 
(M and N) Magnified view of the boxed areas in K and L with PC layers outlined in broken red lines. 
Ectopic granule cells organized around a circular cluster of PCs are indicated with a black arrow-
head. WM, white matter. (O–X) Cresyl violet–stained sections through the developing cerebellum 
at the time points indicated, anterior to the left, with cerebellar folia labeled as above. Note the 
vermis hypoplasia at E16.5 and P0, and striking hypoplasia of both vermis and hemispheres at P14 
(V and X) in the cko. Mb, midbrain. Scale bars: 1 mm (A, E, I, and O), 300 μm (G and U), 100 μm (M).
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Results
Chd7 deletion from neuronal progenitors results in cerebel-
lar hypoplasia. Chd7 is expressed in neural stem cells, 
where it has been reported to regulate the expression of 
developmental and disease-associated genes (7). Chd7 
expression localizes to regions of ongoing neurogenesis 
in the developing brain: the ventricular zone (VZ) and 
hippocampus (Figure 1, A and C), as well as the rhombic 
lip stream, VZ, and EGL of the cerebellum (Supplemen-
tal Figure 1, A–E; supplemental material available online 
with this article; doi:10.1172/JCI83408DS1). Chd7 
expression is maintained in postmitotic, differentiating, 
and migrating neural progenitors in the rostral migra-
tory stream of the forebrain, and upregulated in the dif-
ferentiating inner EGL and internal granule cell layer of 
the cerebellum (Supplemental Figure 1E and Figure 1, A 
and C), implicating Chd7 in neural differentiation. Sev-
eral recent studies have identified roles for Chd7 in adult 
neural stem cell populations in the forebrain (26–28); 
yet Chd7 appears to have a relatively minor role in reg-
ulating neural stem cell expansion in the embryonic and 
perinatal forebrain (26). To determine whether Chd7 
has a function in embryonic neurogenesis, we inacti-
vated Chd7 in neuronal progenitors using a nestin-Cre 
line (29). In agreement with previous demonstrations 
of robust gene recombination in the cerebellar anlage 
by E11 (14), Chd7 mRNA was not detectable in the nes-
tin-Cre Chd7fl/fl conditional knockout (cko) cerebellum 
at E12.5 (Supplemental Figure 1, F and G), and CHD7 
protein, present in cell nuclei in the VZ and migratory 
cells emerging from the rhombic lip in control embryos, 
was absent from these cells (Supplemental Figure 1, H 
and I). The expression of Fgf8 from the mid-hindbrain 
organizer was maintained and the expression patterns 
of the Otx2 and Gbx2 homeobox genes were not altered 
in these mutants (Supplemental Figure 1, J–O), indicat-
ing that the deletion of Chd7 after the establishment of 
this embryonic organizer had little effect on the expres-
sion of genes linked to organizer function (11).
Newborn cko animals lacked Chd7 expression 
throughout the entire brain (Figure 1, B and D). These 
mice were born at the expected Mendelian ratios, but 
postnatal survival rate was reduced (Supplemental 
Table 1). Two mutants survived to P21; these were 
smaller than their littermates, overall brain size was 
reduced accordingly, but cerebellar size was dispro-
portionally reduced (compare cerebella outlined in 
Figure 1, E with F, and G with H). Histological exam-
ination confirmed pronounced hypoplasia of all cer-
ebellar lobules in the vermis (Figure 1, I and J). The 
cerebellar hemispheres were also hypoplastic and dis-
played highly irregular cerebellar foliation with apparently mis-
directed folia (Figure 1, K and L) and ectopic clusters of granule 
cells around clusters of PCs (Figure 1N). Following specific folia 
in serial sections (Supplemental Figure 2) revealed that vermis 
folia IV–V and IX extended abnormally into the lateral hemi-
spheres (Supplemental Figure 2, I and J).
and cerebellar hypoplasia, providing functional genetic evidence 
that Reln downregulation contributes to the cerebellar hypoplasia 
phenotype. Finally, we show that DNA accessibility is reduced at the 
Reln locus, and throughout the genome in CHD7-deficient GCps, 
consistent with a role for CHD7 in maintaining DNA accessibility 
through nucleosome remodeling.
Figure 2. Chd7 regulates the proliferation and survival of cerebellar GCps. (A and 
B) Dorsal whole-mount images of P21 Chd7fl/fl cn and Math1-Cre Chd7fl/fl GCp-specific 
conditional knockout (cko) mouse cerebella, anterior to the top. Note hypoplasia and 
abnormal foliation in the cko. (C–F) Cresyl violet–stained sagittal sections through the 
cerebellum, anterior to the left. Folia are numbered as in Figure 1. Note hypoplasia and 
abnormal folia indicated by an arrowhead and labeled in red in the cko. (G and H) Mag-
nified view of the boxed areas in E and F with PC layers outlined by red broken lines. (I) 
Traced outlines of representative cerebellar sections from cn (black) and cko (blue) mice 
at the indicated time points. Foliation defects are first noted at E18.5 in the vermis and 
P2 in the hemispheres. Hypoplasia becomes evident in the vermis by E18.5 and hemi-
spheres by P10 (see also Supplemental Figure 5). (J) Quantification of GCp proliferation 
in the P0 EGL by BrdU incorporation within a 1-hour time window. The BrdU labeling 
index for the indicated regions representing the fraction of BrdU-positive GCps in the 
EGL as counted in 100-by-100-μm areas. (K) The number of cleaved caspase-3–positive 
(CC3-positive) cells in the EGL per square millimeter of granule cell area at P7 is shown 
for vermis and hemispheres (n = 3 per genotype). *P < 0.05, **P < 0.01, ***P < 0.001, 
Student’s t test. Scale bars: 300 μm (A), 1 mm (C), 100 μm (G).
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growth retardation became evident at 
E16.5 (Figure 1, Q and R), a time point 
shortly after the initiation of GCp prolifer-
ation. At birth (P0), cerebellar hypoplasia 
was most clearly present in the cerebellar 
vermis, where it was associated with a fail-
ure to initiate the formation of most of the 
cardinal cerebellar fissures (Figure 1, S and 
T). By P14, the cerebellum was reduced in 
size, with irregular foliation that included 
expansion of vermis lobules IV–V and IX 
into the hemispheres (Figure 1, U–X). Tak-
en together, these experiments identified 
a critical role for Chd7 in cerebellar growth 
after E14.5, implying a function for CHD7 
in the expansion of cerebellar GCps.
CHD7 regulates the proliferation, differ-
entiation, and survival of cerebellar GCps. 
To specifically determine the function of 
Chd7 within the granule cell lineage, we 
deleted Chd7 from these cells from the 
time of their specification in the rhom-
bic lip using a Math1-Cre transgene (30). 
Transgenic expression resulted in the 
recombination of the Chd7 conditional 
allele from the early stages of EGL forma-
tion at E14.5 (Supplemental Figure 3, C 
and D). By postnatal stages, efficient Chd7 
deletion was evident in GCps in the ante-
rior and central cerebellar vermis, with 
Chd7 expression reduced somewhat in 
anterior lobule VIII and spared in the most 
posterior (posterior IX and X) lobules, in 
agreement with previous reports on the 
activity of this transgene (Supplemen-
tal Figure 3, E–H, and ref. 31). Efficient 
Chd7 deletion was evident throughout the 
entire cerebellar hemispheres (Supple-
mental Figure 3, I and J). Immunostaining 
showed the same pattern of CHD7 protein 
depletion in the cerebellar vermis (Sup-
plemental Figure 3, K–R). Together, these 
experiments identified the granule cell 
lineage as the predominant cell type in the 
postnatal cerebellum that express CHD7, 
with only faint expression remaining in 
cells in the white matter after granule cell–
specific Chd7 deletion (Supplemental Fig-
ure 3, H and J). Efficient Chd7 deletion in 
GCps was further confirmed by quantita-
tive reverse transcriptase PCR (RT-PCR) 
analysis of purified GCps from P7 animals 
(Supplemental Figure 3S).
The GCp-specific conditional mu tants, from here on referred 
to as cko animals, survived to adulthood. Examination of whole-
mount P21 cerebella revealed significant cerebellar hypoplasia 
(Figure 2, A and B). Histological sections confirmed hypoplasia of 
To identify the developmental stage at which these pheno-
types first emerge, sagittal sections from E12.5 to P14 cerebella 
were examined. Cerebellar size was normal at E12.5 (Supplemen-
tal Figure 1, F–I) and E14.5 (Figure 1, O and P). Clear cerebellar 
Figure 3. Deletion of Chd7 from GCps results in PC abnormalities. (A) PC counts in cn and cko mouse 
P21 cerebella. Note the significant reduction in total PC number in the cko. (B) Lobule-specific PC 
counts. Note the significant reduction in PC number in the anterior and central lobules of the cko. (C–E) 
PC density in relation to the total vermis volume (mm3) (C), lobule granule cell area (mm2) (D), and 
length of the PC layer (mm) (E) (n ≥ 5 per genotype). *P < 0.05, **P < 0.01, ***P < 0.001, Student’s t 
test. (F–U) Examples of Purkinje cell protein 2 (PCP2) immunostains to visualize PCs in P7 cerebellar 
sections through the vermis (F–I) or hemispheres (J–M), with nuclear DAPI counterstain, anterior to the 
left. Magnified views of PC layers indicated by white boxed areas in corresponding low-power images 
are depicted in H, I, L, and M. Note the occasional disorganized PC distribution in the cko vermis (I), and 
more pronounced clusters of mislocalized PCs in the cko cerebellar hemispheres (M). (N–U) Exam-
ples of PCP2 immunostains to visualize PCs in P21 cerebellar sections through the vermis (N–Q) or 
hemispheres (R–U), with nuclear DAPI counterstain, anterior to the left. Magnified views of PC layers 
indicated by white boxed areas in corresponding low-power images are depicted in P, Q, T, and U. Note 
the occasional multilayered PC distribution in the cko vermis (Q), and more pronounced clusters of mis-
localized PCs in the cko cerebellar hemispheres (U). Scale bars: 300 μm (F), 100 μm (H and P), 1 mm (N).
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This analysis revealed interesting dif-
ferences: whereas vermis growth was 
clearly reduced from E18.5 onward, 
hypoplasia of the hemispheres became 
obvious only from P7 (Figure 2I).
To determine the underlying cause 
of cerebellar hypoplasia, GCp prolif-
eration was quantified by BrdU incor-
poration between E18.5 and P14. This 
analysis revealed a significant reduc-
tion in GCp proliferation in vermis 
lobules I–VIII at early postnatal stages 
(Supplemental Figure 6, A and B), most 
prominent at P0 (Figure 2J). No signif-
icant reduction in GCp proliferation 
was seen in hemispheres (Supplemen-
tal Figure 6D). These results indicated 
that reduced GCp proliferation likely 
contributed to reduced growth of the 
vermis, but not the hemispheres. To 
assess the contribution of apoptosis, 
sections were stained with an antibody 
against activated cleaved caspase-3. 
The number of apoptotic GCps was 
increased in both vermis and hemi-
spheres at P7 (Supplemental Figure 
6, E and F), but reached statistical 
significance only in the hemispheres 
(Figure 2K). These data suggested 
that the reduced postnatal growth of 
the hemispheres was largely caused 
by increased cell death, whereas both 
proliferative and apoptotic changes 
contributed to vermis hypoplasia.
Reduced PC numbers in Chd7 cko 
cerebella. To determine the impact of 
the diminished production of granule 
neurons in the cerebellum on PCs, PC 
number and distribution were exam-
ined. Total PC numbers were reduced 
in cko cerebella at P21 (Figure 3A). A finer analysis of PC numbers 
across different cerebellar regions revealed that the reduction in PC 
number was due to fewer PCs in lobules I–VII of cko animals (Figure 
3B), in agreement with the pronounced hypoplasia of anterior and 
central cerebellar lobules in the mutants (Figure 2D). PC density was 
not altered, indicating that the reduction in PC numbers remained 
proportional to the reduced cerebellar size (Figure 3, C–E). PCs in 
the cko cerebellar vermis were organized in monolayers for most 
of the cerebellum, with small regions of slightly disorganized cells 
observed at P7 (Figure 3, F–I) and P21 (Figure 3, N–Q). By contrast, 
large patches of disorganized PCs were present in the hemispheres 
at P7 (Figure 3, J–M) and P21 (Figure 3, R–U).
To understand the cause of these abnormalities, we investigat-
ed the distribution of LHX1/5+ PC progenitors over time as they 
migrate from their site of origin, the VZ toward the pial surface 
(23). This analysis revealed a relatively normal PC distribution, 
including formation of the PC plate under the pial surface at E16.5 
lobules I–VIII (Figure 2, C and D), with the most striking hypoplasia 
presenting in central lobules. All lobules in the hemispheres were 
smaller, and vermis folia IV–V and IX were again found to extend 
abnormally into the hemispheres (Supplemental Figure 4 and Fig-
ure 2, E and F) with associated foliation irregularities (Figure 2, G 
and H). Cerebellar development was followed from E13.5 to reveal 
the first signs of reduced cerebellar growth. Surface area mea-
surements to estimate cerebellar size were performed on Cresyl 
violet–stained sagittal sections through the most medial aspect of 
the cerebellar vermis. Delayed initiation of cerebellar foliation in 
the vermis became evident at E17.5 (Supplemental Figure 5) before 
cerebellar size was significantly altered (mean area ± SEM = 0.26 
± 0.068 mm2 in controls, 0.26 ± 0.026 mm2 in cko). Hypoplasia 
became evident at E18.5 (mean ± SEM = 0.50 ± 0.014 mm2 in con-
trols, 0.30 ± 0.026 mm2 in cko). To visualize the trajectory of cer-
ebellar growth, representative sections (vermis and hemisphere) 
from control and cko cerebella were traced and overlaid (Figure 2I). 
Figure 4. Deletion of Chd7 from GCps leads to developmental delay and motor coordination deficits. 
Behavioral assessments of separate cohorts of adult (D–F, H, and I) cn (male n = 12, female n = 11) and cko 
(male n = 10, female n = 12) mice and pups for analysis of developmental milestones (cn n = 20, cko  
n = 22) or ultrasonic vocalizations (USVs) (cn n = 21, cko n = 23). (A–C) The percentage of pups at the 
indicated postnatal ages demonstrating the full righting reflex (A), a score of 1 or higher for negative 
geotaxis (B), or the full reaching response (C). Note the delay in acquiring these motor milestones in cko 
compared with cn animals (*P ≤ 0.05, χ2 tests). (D and E) The mean latency of male (D) and female (E) mice 
to fall from the rotarod. Note the significant difference between the male cko and cn animals (*P ≤ 0.05, 
repeated-measures ANOVA, with Student’s t test as post hoc analysis). (F) The mean number of ultrasonic 
vocalizations per minute at the indicated postnatal ages for cn and cko mice (repeated-measures ANOVA). 
(G) Average number of marbles buried within 30 minutes. Note no significant difference between the 
groups (between-subjects ANOVA). (H and I) The mean duration of total social investigation of an age- and 
sex-matched novel conspecific at P21 (H) and in adulthood (I). No significant difference between the cn and 
the cko groups was observed (repeated-measures ANOVA).
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(Supplemental Figure 7, A–H). Abnormal PC organization was evi-
dent by E18.5, with more dispersed PC progenitors in the central 
vermis (Supplemental Figure 7Q) and apparently mislocalized 
progenitors in the hemispheres (Supplemental Figure 7, S and T), 
consistent with the altered PC distributions seen in these regions at 
later stages. As CHD7 is also expressed in cells in the VZ, we asked 
whether nestin-Cre cko mice, in which Chd7 has been deleted from 
these progenitors in addition to GCps, exhibited more pronounced 
PC developmental defects. Indeed, although a clear PC plate still 
formed in the medial cerebellum by E16.5 (Supplemental Figure 
7I), PC distribution was clearly irregular in the rest of the cerebel-
lum (Supplemental Figure 7, J–L). Mislocalized cells were evident 
in the vermis and hemispheres by E18.5 (Supplemental Figure 7, 
U–X). Together, these findings suggested that the deletion of Chd7 
from the early VZ progenitors contributed to PC defects in nes-
tin-Cre cko mice, although we cannot rule out the possibility that 
the deletion of Chd7 from the rhombic lip stream and EGL earlier 
than in Math1-Cre cko mutants also contributed to these defects.
GCp-specific Chd7 conditional mouse mutants exhibit motor 
delay and coordination deficits. Next, we asked whether the cere-
bellar defects were sufficient to cause behavioral abnormalities 
in these mice. Mutant mouse pups exhibited normal growth (Sup-
Figure 5. CHD7 regulates Reln gene expression in GCps. 
(A) Volcano plot of RNA-Seq data comparing gene 
expression of purified GCps from P7 cko and cn mice. 
Red points indicate genes with statistically significant 
(FDR < 0.05, n = 2) differences in expression. Reln is 
highlighted in blue. (B–M) In situ hybridization with an 
antisense Reln probe on sagittal cerebellar sections at 
the indicated time points. Note reduced Reln expression 
in the rhombic lip stream at E14.5 (arrow in E), anterior 
vermis of E18.5, P1, and P7 cerebella (red dashed line 
in G, I, and K), and all lobules of the hemispheres at 
P7 (M), with normal expression in the posterior vermis 
(navy dashed line in G, I, and K). IGL, internal granule 
layer. (N) Quantification of Reln transcript levels in 
purified P7 GCps confirms significant reduction in Reln 
expression in cko GCps (3 samples of purified GCps 
extracted from pooled cerebellar samples of each 
genotype). (O–W) Immunostaining for DAB-1 on sagittal 
sections of P7 mouse cerebella. High-magnification 
views of indicated regions in O, P, S, and T are shown 
in Q, R, and U–W, respectively. Increased DAB-1 protein 
levels in the anterior vermis lobules and hemisphere of 
cko mice are indicative of reduced RELN signaling. (X) 
Western blot analysis of DAB-1 protein levels in lobules 
I–VIII and IX–X. Note the increase in protein levels in 
cko samples (n = 3) compared with cn (n = 2), with more 
marked increases identified in lobules I–VIII of the cko. 
(Y) DAB-1 protein levels quantified relative to GAPDH. 
*P < 0.05, **P < 0.01, Student’s t test. Scale bars: 300 
μm (B, H, and O), 100 μm (Q).
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plemental Figure 8A). Pups were assessed for the acquisition of 
developmental milestones, which revealed a delay in acquiring the 
righting reflex (Figure 4A), the ability to turn around when placed 
head facing downward on a sloping platform (negative geotaxis; 
Figure 4B), and the ability to reach out toward an object (Figure 
4C). To determine whether adult cko animals had any motor defi-
cits, their motor coordination on a revolving rotarod was exam-
ined. Male cko mice performed significantly worse on this test 
than their sex-matched control littermates (Figure 4D), whereas 
female cko mice showed no difference compared with controls 
(Figure 4E). There were no significant differences in body weight 
or grip strength between control and cko animals (Supplemen-
tal Figure 8, B and C), excluding general muscle weakness as a 
potential cause of this motor phenotype. The performance of cko 
animals of both sexes improved to a similar extent over the 3 days 
of testing, indicating that these mutants had no deficit in motor 
learning. Mutant animals showed no signs of repetitive behaviors 
(Figure 4F) or anxiety (Supplemental Figure 8, D and E).
Cerebellar defects and dysfunction have also been proposed 
to be associated with autism spectrum disorders (reviewed in ref. 
32). We therefore also performed tests to assess social interactions 
and communication. Mice communicate via vocalizations in the 
ultrasonic and sonic ranges, particularly in social situations such 
as when pups are separated from the mother (33). Mutant pups 
exhibited no difference in ultrasonic vocalizations (Figure 4G). 
Social investigation of conspecific age- and sex-matched mice 
by juvenile cko mice was normal (Figure 4H), as were reciprocal 
social investigations (Figure 4I) and sociability in the 3-chamber 
social approach test (Supplemental Figure 8F) in adult mice. In 
contrast to the Chd7 heterozygous mouse models (34, 35), no dif-
ferences were observed in olfactory discrimination tests (Supple-
mental Figure 8, G and H), consistent with the cerebellar-specific 
Chd7 deletion in these mutants.
In addition to the well-established role of the cerebellum in 
sensorimotor function, structural and functional studies have 
also implicated the cerebellum in cognition and spatial processing 
(36). In humans, cognitive tasks tend to activate central cerebel-
lar lobules VI, VII, and Crus I/II (reviewed in refs. 37, 38). Given 
the particularly strong phenotypes seen in the central cerebellar 
lobules of the cko animals, we also evaluated the performance of 
these mutants in the Morris water maze test, a cognitive task that 
assesses visual-spatial processing and memory. These conditional 
Figure 6. Reln downregulation is partly 
responsible for cerebellar hypoplasia in 
GCp-specific Chd7 cko mice. (A–C) Sagit-
tal sections of BrdU-treated cn, cko, and 
reln-rescue cerebella at P1, immunostained 
with anti-BrdU antibody (brown). Dashed 
lines indicate anterior (black), central (red), 
and posterior (navy) cerebellum used for BrdU 
counts. (D) Quantification of the BrdU label-
ing indices in regions indicated in A–C. Note 
reduced GCp proliferation in the central lob-
ules (VI–VIII) of the cko mice and restoration 
in reln-rescue mice (n = 3 per genotype). (E–J) 
Cresyl violet–stained sagittal sections of the 
cerebellar vermis at P21; sex-genotype com-
binations are indicated, anterior to the left. 
Blue shading indicates the central lobules 
(VI–VII); lobule X is highlighted in pink. (K) 
Quantification of the volume of lobules VI–VII 
relative to lobule X calculated from serial 
sections through the cerebellar vermis. Note 
the rescue of the central lobule hypoplasia in 
female reln-rescue mice (n = 3 per genotype). 
(L) Quantification of the volume of lobules 
I–V in the cko and reln-rescue mice relative 
to lobule X calculated from serial sections 
through the cerebellar vermis. (M) Quan-
tification of Reln transcript levels in E18.5 
whole cerebella. Note that Reln expression 
is reduced in the cko and restored in the 
reln-rescue irrespective of sex (n = 5 per gen-
otype). *P < 0.05, **P < 0.01, ***P < 0.001, 
Student’s t test.
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sufficient numbers of pure, primary GCps can be isolated ex 
vivo. A total of 881 coding transcripts with significantly changed 
expression (FDR < 0.05) were identified in Chd7-deficient GCps, 
compared with controls. Nearly equal numbers of genes were 
downregulated (n = 435) or upregulated (n = 446) (Figure 5A and 
Supplemental Table 2).
This experiment revealed significant downregulation of the 
Reln gene (labeled in blue in Figure 5A). Homozygous mutation 
of the RELN gene is associated with pronounced cerebellar hypo-
plasia in humans and mice (19, 39), suggesting that Reln down-
regulation might contribute to cerebellar hypoplasia in Chd7 cko 
mutants. In situ hybridization studies revealed a subtle reduction 
of Reln expression in the EGL already at E14.5 (Figure 5, D and E), 
E18.5 (Figure 5, F and G), and substantial downregulation in Chd7- 
mutants exhibited no deficits in this task compared with control 
animals (Supplemental Figure 8I).
In conclusion, our behavioral tests indicate that cerebel-
lar hypoplasia and PC hypocellularity in Chd7 cko mutants are 
associated with developmental delay and motor coordination. 
By contrast, these defects are not sufficient to cause deficits in 
social behaviors or cognition.
CHD7 controls gene expression levels in GCps. Chd7 encodes a 
chromatin remodeling factor that has been postulated to function 
as a “transcriptional rheostat” to maintain developmental gene 
expression at physiological levels (9). Thus, to identify CHD7- 
regulated genes in GCps, a direct comparison of the Chd7-defi-
cient and control transcriptome was performed by RNA sequenc-
ing (RNA-Seq). RNA was isolated from purified GCps at P7, when 
Figure 7. CHD7 deletion alters chromatin organization and reduces DNA accessibility at the Reln locus. (A) Heatmaps representing all significantly changed 
ATAC-Seq peaks ± 500 bp between control (CTRL) and cko (KO) GCps (n = 3). Note reduced DNA accessibility in KO samples for the majority of peaks (CTRL/
KO peaks), with a few showing increased DNA accessibility in the KO (KO/CTRL peaks). (B) DNase-Seq (purple) (45) and ATAC-Seq reads mapped over the 
Reln gene in control (CTRL ATAC-Seq, green) and cko (KO ATAC-Seq, orange) P7 GCps. Peaks are indicative of regions of “open” chromatin with high DNA 
accessibility. Blue stars indicate ATAC-Seq peaks that are significantly different in CTRL and KO cells. (C) Visualization of normalized CTRL (green) and KO 
ATAC-Seq (orange) reads, and H3K4me1 ChIP-Seq reads from WT GCps (red) that mapped to intron 8, the Reln transcriptional start site (TSS), and a region 
127 kb upstream of the Reln TSS. Note significantly reduced DNA accessibility at the intronic and upstream regions in KO cells compared with CTRL cells.
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explain the sex-specific rescue effects seen (Figure 6M). In sum-
mary, our genetic studies confirmed that reduced Reln expres-
sion significantly contributes to the proliferation deficit of Chd7- 
deficient GCps in central cerebellar lobules and may affect cere-
bellar growth in a sex-specific manner.
CHD7 is required for the maintenance of DNA accessibility at the 
Reln promoter. CHD7 is thought to function primarily by modu-
lating DNA accessibility at developmental regulatory elements 
through its ATP-dependent chromatin remodeling activity. We 
hypothesized that CHD7 assists in the maintenance of an “open,” 
accessible chromatin structure at CHD7-regulated regulatory ele-
ments in primary GCps. To address this question, DNA accessibil-
ity in control and Chd7 cko GCps was compared using an assay for 
transposase-accessible chromatin with high-throughput sequenc-
ing (ATAC-Seq) (44). In total, 142,047 ATAC-Seq peaks, i.e., 
regions where the DNA is accessible to transposase, were iden-
tified in the control cells (Supplemental Table 3). We compared 
the ability of ATAC-Seq to identify regions of accessible DNA 
with DNase I hypersensitive sites sequencing (DNase-Seq) data 
recently published from GCps (45). Our analysis of DNase-Seq 
data identified 50,022 accessible peaks in P7 GCps, 88% (43,782) 
of which were within 100 bp of an ATAC-Seq peak, indicating that 
ATAC-Seq can reliably identify accessible regions.
Having validated the ATAC-Seq approach, we asked whether 
DNA accessibility was significantly altered at any of these regions 
in Chd7-deficient GCps. We identified 4,921 regions that showed 
significantly reduced DNA accessibility in Chd7-deficient GCps 
(CTRL/KO, Figure 7A), and only 210 regions with increased 
accessibility (KO/CTRL, Figure 7A). This finding suggested that 
CHD7 primarily functions in the maintenance of open, accessible 
chromatin states in the genome.
Next, we determined whether any of these differentially reg-
ulated regions were in close vicinity of differentially expressed 
genes. Four hundred seventy-two (9.6%) of the peaks with reduced 
accessibility mapped to a location within 1 kb of a differential-
ly expressed gene identified by RNA-Seq. Of these regions, 333 
(70.6%) and 139 (29.4%) were located within 1 kb of a downreg-
ulated and upregulated gene, respectively. Thus, although there 
appears to be some association of downregulated gene expression 
with reduced DNA accessibility, this is by no means absolute. A 
similar observation was made for regions that showed increased 
accessibility in cko cells. Of the 210 peaks, 20 (9.5%) mapped to 
a location within 1 kb of a differentially expressed gene. Of these 
peaks, 11 (55%) and 9 (45%) were within 1 kb of a downregulated 
and upregulated gene, respectively.
Finally, we asked whether the accessibility of any poten-
tial regulatory elements at the Reln locus was altered in Chd7- 
deficient GCps. A direct comparison of DNase-Seq and ATAC-Seq 
profiles over the Reln locus (Figure 7B) clearly showed the supe-
riority of the ATAC-Seq approach in being able to unambiguous-
ly identify regions of DNA accessibility. A statistically significant 
reduction in DNA accessibility was evident at 6 putative regulato-
ry elements at the Reln locus (blue stars, Figure 7B). As examples 
of regions with reduced DNA accessibility, zoomed-in views of a 
region in intron 8 and 127 kb upstream of the transcriptional start 
site are shown (Figure 7C). Although accessibility at the Reln tran-
scriptional start site also appears to be reduced, these changes did 
deficient GCps in the anterior and central cerebellum at P1 (Figure 
5, H and I) and P7 (Figure 5, J and K). In agreement with the effi-
cient deletion of Chd7 throughout the lateral cerebellum (Supple-
mental Figure 3J), Reln expression was strongly downregulated in 
cerebellar hemispheres (Figure 5, L and M). Quantitative RT-PCR 
analysis showed that Reln expression was reduced by over 50% in 
cko GCps, compared with control GCps (Figure 5N). RELN sig-
naling is associated with the degradation of the intracellular pro-
tein DAB-1 (21, 40–42), and therefore, reduced RELN signaling 
should result in increased levels of DAB-1 protein. Immunostain-
ing with a DAB-1–specific antibody revealed a clear upregulation 
of DAB-1 protein in PCs in the anterior and central vermis lobules 
and hemispheres of Chd7 cko cerebella (Figure 5, S–V), compared 
with lobule X (Figure 5W) and control cerebella (Figure 5, O–R). 
These findings were corroborated by immunoblotting, which also 
revealed increased DAB-1 protein in the cko cerebellum, compared 
with the control cerebellum (Figure 5, X and Y). These observations 
confirmed that Reln downregulation was sufficient to cause a sub-
stantial reduction in RELN signaling in the developing cerebellum 
and identify CHD7 as an important regulator of Reln gene expres-
sion and signaling levels in the developing cerebellum.
Reduced RELN signaling contributes to cerebellar hypoplasia 
in Chd7 cko mice. To test whether reduced RELN signaling was 
responsible for cerebellar hypoplasia in Chd7 cko mice, we sought 
to rescue this phenotype by increasing Reln expression in these 
mutants in vivo. For this purpose, we used a nestin-Reln transgen-
ic mouse (RelnTG) reported to misexpress Reln throughout the 
developing cerebellum at 10%–20% of WT levels until P5 (43). 
Despite its low, transient, and ectopic expression, this transgene 
was capable of partially rescuing the cerebellar hypoplasia in 
homozygous reeler mice (43). We therefore generated Math1-Cre 
Chd7fl/fl RelnTG (referred to as reln-rescue) mice. We first asked 
whether the transgene could normalize the GCp proliferation 
defect observed in Chd7 cko mutants at P1 (Figure 6, A–D). The 
defect was fully corrected in reln-rescue mice (Figure 6D). To 
examine whether transient transgenic Reln expression had any 
lasting effect on the size of these central cerebellar lobules, P21 
cerebella were examined. As Chd7 is not deleted (Supplemen-
tal Figure 3, H and R) and Reln expression is not altered (Figure 
5K) in lobule X as a result of the inefficiency of the Math1-Cre 
transgene in the posterior cerebellum, we measured the size of 
the central lobules as a fraction of lobule X as internal control. 
This analysis revealed a significant increase in the relative size of 
the central lobules VI–VII in female reln-rescue mice, compared 
with Chd7 cko mice (Figure 6, E, F, and K). By contrast, RelnTG 
expression did not significantly increase the size of the central 
lobules in male mice (Figure 6, G, H, and K). Control RelnTG 
mice had a normal cerebellar size and morphology (Figure 6, 
I–K). The relative size of anterior lobules (I–V) was not rescued by 
RelnTG expression (Figure 6L), consistent with the lack of signifi-
cant effect on GCp proliferation here (Figure 6D). Quantification 
of Reln transcript levels in E18.5 cerebella confirmed an almost 
2-fold upregulation of Reln transcripts in RelnTG mice compared 
with mutants (Figure 6M), consistent with the near-complete res-
cue of proliferation at P1 (Figure 6D). Importantly, there was no 
difference in Reln levels between male and female cko cerebella, 
indicating that sex differences in Reln expression levels could not 
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in women (46, 47). Sex-specific differences in the anatomical and 
behavioral phenotype of heterozygous reeler mice (Relnrl/+) have 
also been reported (48). PC degeneration has been identified from 
postnatal day 15 in male Relnrl/+ mice, and motor dysfunction has 
been reported in adult males (49, 50). Reduced Reln expression and 
neuroactive steroid levels appear to be critical in the pathophysiol-
ogy of the Relnrl/+ phenotype, since administration of 17β-estradiol 
protects against PC degeneration in males (49). Taken together, 
these studies are indicative of a complex interplay between RELN 
signaling and sex hormones during cerebellar development. In 
the present study, we ruled out a simple model whereby Reln gene 
expression in GCps differs in the 2 sexes (Figure 6M).
We report here that adult GCp-specific Chd7 cko mutant mice 
with cerebellar hypoplasia exhibit a range of behavioral deficits. 
The identification of developmental motor delay and mild motor 
deficits in these animals implies that cerebellar hypoplasia may 
underlie some of these features in CHARGE syndrome patients. 
We propose that clinical studies to assess and compare the severity 
of motor delay and coordination deficits in CHARGE syndrome 
patients with or without cerebellar hypoplasia will be important to 
delineate the contribution of cerebellar defects to these deficits. 
Our findings may also have implications for understanding oth-
er clinical features of CHARGE syndrome. We note that several 
CHD7-regulated genes implicated in other cell types and tissues 
affected in CHARGE syndrome (e.g., Sema3a, neural crest; ref. 
51) are also dysregulated in GCps, perhaps indicative of common 
gene regulatory mechanisms in different developmental contexts.
Interestingly, we detected no deficits in social behavior in these 
mutants. This finding is important to consider in the context of cer-
ebellar anomalies described in patients diagnosed with autism. For 
example, hypoplasia of the central vermis lobules VI–VII has been 
reported in autism spectrum disorder (ASD) cases (52, 53). Our 
data suggest that marked hypoplasia of the central cerebellar lob-
ules, associated with reduced PC numbers in these lobules, is not 
sufficient to cause social deficits in mice. This conclusion has to be 
tempered by consideration of several caveats. First, mouse mod-
els might not be ideal for addressing this question, as the nature 
of cerebellar–prefrontal cortex connections may be qualitatively 
or quantitatively different from that in primates and humans (12). 
Second, the behavioral tests used to evaluate social investigations 
in mice may not be sensitive enough to detect appropriate changes 
in behavior. Another neuroanatomical anomaly frequently reported 
in the context of ASD is the reduction in PC number in postmortem 
brain samples from ASD patients (reviewed in ref. 54). It was report-
ed recently that conditional deletion of the Tsc1 gene from cerebellar 
PCs alone was sufficient to cause autism-like behaviors in a mouse 
model (55). Our data indicate that a reduction in PC number as a 
consequence of disruption of the normal developmental process is, 
by itself, not sufficient to cause autism-like social behaviors in mice.
A number of nucleosome remodeling factors appear to be criti-
cal for normal brain development, and mutations that disrupt their 
normal function are associated with neurodevelopmental disor-
ders (56). Identifying the changes in chromatin structure that result 
from disrupted function of these factors is an important step toward 
understanding the mechanisms that underlie these conditions. The 
prevailing model for CHD7 function is that CHD7 remodels chro-
matin by sliding nucleosomes along chromatin to modulate DNA 
not reach statistical significance. Finally, we confirmed that these 
regions were positive for the H3K4me1 histone modification, a 
marker of regulatory regions to which CHD7 can be recruited (8). 
Thus, our findings are consistent with a model whereby CHD7 is 
recruited to regulatory elements at the Reln locus, where it directly 
modulates chromatin structure. Together, these observations sug-
gest a crucial role for CHD7 in maintaining an accessible, “open” 
chromatin structure throughout the genome and at the Reln locus.
Discussion
In this article we define an important role for CHD7 in the expansion 
of the GCp pool in the perinatal cerebellum. Together with our pre-
vious work (11), we conclude that CHD7 controls cerebellar growth 
at 2 distinct stages of cerebellar development. CHD7 is essential for 
the maintenance of rhombomere 1 identity and Fgf8 expression in 
the embryonic isthmus organizer, with disruption of the latter pre-
disposing the embryo to cerebellar vermis hypoplasia. In this arti-
cle, we show that CHD7 expression becomes localized to cerebellar 
GCps where it regulates GCp proliferation and survival. CHD7 dele-
tion from GCps as well as PC progenitors in the VZ from E12.5 with 
nestin-Cre resulted in a more severe phenotype, potentially impli-
cating CHD7 expression in the VZ in cerebellar development. Chd7 
gene deletion specifically in the cerebellar VZ using Ptf1a-Cre will be 
necessary to address this possibility directly. We show that reduced 
RELN signaling in CHD7-deficient GCps can partially account for 
the cerebellar hypoplasia. The RelnTG line we used in these experi-
ments does not express the Reln transgene past P5, likely explaining 
the limited phenotypic rescue achieved by P21. Nevertheless, the 
possibility that other genes deregulated in CHD7-deficient GCps 
also contribute to reduced GCp expansion remains likely.
The exact mechanism whereby reduced RELN signaling results 
in GCp proliferation defects is not known. In homozygous reeler 
(Relnrl/rl) mutants, PC migration from the VZ is disrupted, presum-
ably leading to a deficit in PC-derived mitogenic signals (23). PC 
positioning is abnormal in our mutants, especially in the cerebellar 
hemispheres, suggesting that PC disruption may contribute to the 
hypoplastic phenotype. Expression analysis of several genes tran-
scriptionally regulated by SHH signaling (Gli1, Ptch1, and Mycn) 
by in situ hybridization and quantitative RT-PCR revealed no sig-
nificant downregulation in their expression, suggesting that PC 
disruption in our mutants may affect GCp proliferation in an SHH- 
independent manner. Alternatively, PC defects may not be respon-
sible for GCp proliferation defects, and RELN downregulation may 
affect GCp proliferation in a cell-autonomous manner. Consistent 
with this latter possibility, transcripts encoding the RELN receptors 
ApoER2, VLDLR, and ephrin B1, B2, and B3 are present in GCps 
(RNA-Seq data, Supplemental Table 2). GCp-specific deletion 
of Reln and combinations of genes encoding the different RELN 
receptor genes will be necessary to examine this possibility.
The finding that increased Reln expression had a significant 
effect on the size of the central lobules in female cko mice, but not 
males (Figure 6K), suggested that perhaps female mice were more 
sensitive to changes in Reln expression. Interestingly, sex-genotype 
interactions appear to be important in the expression of psychiatric 
diseases associated with RELN. Specifically, genome-wide associ-
ation studies have identified common variants in the RELN gene 
that increase the risk of schizophrenia and bipolar disorder only 
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BD Biosciences 347580), and cleaved caspase-3 (Asp 175) (1:150; Cell 
Signaling Technology 9661). For DAB-1 and PCP2 detection, sec-
tions were incubated with Alexa Fluor–labeled secondary antibod-
ies (1:200; Life Technologies) and counterstained with DAPI. Slides 
were mounted with Citifluor (Citifluor Ltd.), and fluorescent images 
were captured using a Nikon Eclipse 80i microscope with a Nikon 
Y-QT Hamamatsu C4742-95 camera. For BrdU and cleaved caspase 
antibodies, sections were incubated with polyclonal goat anti-mouse 
or goat anti-rabbit biotinylated secondary antibody (1:200; Dako) for 
1 hour. Signal was amplified using the VECTASTAIN Avidin/Biotin 
Complex (ABC) kit (1:200; Vector Laboratories Ltd.), and visualized 
with 3,3′-diaminobenzidine substrate (0.03%; Sigma-Aldrich). Sec-
tions were then counterstained with hematoxylin (30 seconds), dehy-
drated, mounted in DPX, and imaged with a Nikon Eclipse 80i.
BrdU. Pregnant females or pups were given 1 i.p. injection of 50 
mg/kg or 20 mg/kg 5′-bromo-2′-deoxyuridine (BrdU), respectively. 
Mice were sacrificed 1 hour later, and brains were fixed with 4% PFA 
overnight at 4°C, washed in PBS, and processed as described above. 
The BrdU labeling index was calculated by counting of the num-
ber of BrdU-labeled cells and the total number of cells in the EGL in 
100-by-100-μm areas (2–3 fields per lobule) using a Nikon Eclipse 80i 
microscope. The BrdU-positive GCps were then plotted as a fraction of 
the total number of GCps per lobule.
Western blot. P7 cerebella were dissected in PBS and lobules IX and X 
separated from lobules I–VIII. Tissue was lysed in 8 M urea, 1% CHAPS, 
50 mM Tris (pH 7.9) followed by the removal of DNA by centrifugation. 
Proteins (10 μg per lane) were resolved on a Mini-PROTEAN precast gel 
(Bio-Rad, United Kingdom) and transferred to a nitrocellulose membrane 
(Bio-Rad, United Kingdom). After blocking with 0.5% nonfat milk pow-
der in TBS with 0.5% Tween-20 (TBST), the membrane was incubated 
with primary antibodies (rabbit anti–DAB-1 [C-terminal], Sigma-Aldrich, 
D1569, 1:5,000; rabbit anti-GAPDH, Abcam, ab181602, 1:10,000) in 5% 
BSA, TBST overnight at 4°C. After washing and incubation with HRP-con-
jugated secondary antibody (Millipore) for 1 hour at room temperature, 
HRP conjugates were detected using Clarity Western ECL reagent (Bio-
Rad). Gels were visualized on a Bio-Rad gel doc system and images ana-
lyzed with Image Lab (Bio-Rad) and prepared using Adobe Photoshop.
In situ hybridization. In situ hybridization was performed using 
standard methods (60). DNA templates were produced by PCR ampli-
fication from mouse genomic DNA. The PCR primers used were: Chd7 
(exon3) forward 5′-TTGGTAAAGATGACTTCCCTGGTG-3′, reverse 
5′-GTTTTGGCGTGACAGTTTTTGC-3′; Reln (exon 65) forward 
5′-CAACAGAAGACGAAGGTCGCTTAG-3′, reverse 5′-ACAAGTAG-
GTCAAAGTCCAGCAGC-3′. Digoxigenin-labeled antisense probes 
for Chd7 and Reln were produced by in vitro transcription using a DIG 
RNA labeling kit with T7 RNA polymerase (Roche).
GCp purification and quantitative PCR. P7 cerebella were dissected 
in DPBS (Gibco), and lobules IX and X were removed. The cerebella of 
the individuals from each genotype were pooled. Cells were dissociat-
ed using Papain I (100 U; Worthington) followed by trituration. Gran-
ule cell precursors were isolated by Percoll fractionation with a 35% 
and 65% Percoll gradient (Sigma-Aldrich) as previously described (14).
Total RNA was extracted from the purified granule cells of 3 samples 
of each genotype using Trizol (Invitrogen). cDNA was synthesized from 
200 ng of RNA using the nanoScript 2 Reverse Transcription kit (Prim-
erdesign Ltd.) with random hexamer primers. Quantitative RT-PCR was 
performed on a Stratagene Mx3000P (Agilent Technologies) using the 
accessibility at key developmental regulatory elements (57). We 
identified a striking reduction in DNA accessibility throughout the 
genome in CHD7-deficient cells, consistent with a role for CHD7 
in the maintenance of regions of open, accessible chromatin. This 
finding is in keeping with the activity of the CHD7 homolog, kismet, 
that was operationally identified as a Trithorax family member that 
functions as an antagonist of Polycomb factors (58), which promote 
chromatin compaction and gene repression (59).
In conclusion, we have defined a critical role for CHD7 in cer-
ebellar GCp expansion and identified CHD7 as a regulator of Reln 
gene expression, thereby linking CHD7 to a pathway associated 
with cerebellar hypoplasia and neuropsychiatric disease in humans. 
Behavioral analyses of GCp-specific mouse mutants revealed 
important impacts of cerebellar hypoplasia on motor development 
and function. These findings have implications for understanding 
the neurodevelopmental basis of motor delay in CHARGE syn-
drome. Intriguingly, our data do not support a view where cerebel-
lar hypoplasia per se is sufficient to cause behavioral deficits in the 
social domain, at least not in mouse models. Finally, we identify a 
crucial molecular function of CHD7 in the maintenance of open, 
accessible chromatin in primary neuronal progenitors.
Methods
Mice. The Chd7flox (28), nestin-Reln transgenic (RelnTG) (43), Math1-
Cre (30), and nestin-Cre (29) mouse lines, provided by Pete Scambler 
(Institute of Child Health, London, United Kingdom), Tom Curran 
(Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, 
USA), David Rowitch (UCSF, San Francisco, California, USA), and 
Gill Bates (University College London, London, United Kingdom), 
respectively, were genotyped by PCR using tail or ear DNA. Mouse 
lines were backcrossed with C57BL/6J mice for at least 3 generations. 
Conditional neural-specific mutants were obtained from nestin-Cre 
Chd7fl/+ × Chd7fl/fl matings. Conditional GCp-specific mutants were 
obtained from Math1-Cre Chd7fl/fl × Chd7fl/fl matings. For behavioral 
tests, sex-balanced matings were used to produce animals for test-
ing to control for any sex-specific parental genotype effects. Juvenile 
(3-week-old) C57BL/6J mice used as conspecifics were purchased 
from Charles River Laboratories and group-housed by sex.
Mice were bred in the Biological Services Unit at Guy’s Campus 
or the Institute of Psychiatry, Psychology & Neuroscience, King’s 
College London.
Histology. Samples were dissected in PBS, fixed overnight in 4% para-
formaldehyde (PFA) at 4°C, dehydrated, and embedded in paraffin wax. 
Serial, sagittal sections were cut at 10 μm and left to dry overnight at 42°C.
Volumetric analysis and PC counts. The surface area of serial, Cresyl 
violet (0.1%)–stained sections was measured in ImageJ (NIH) and the 
vermis volume calculated by multiplication of the total surface area by the 
section thickness (10 μm). PCs were counted in 5 separate, nonadjacent 
10-μm vermis sections (3 cerebella per genotype) in H&E-stained sections.
Immunohistochemistry. Sections were deparaffinized in xylene 
and rehydrated, heated in a sodium citrate buffer (pH 6.0), permea-
bilized in 0.2% Triton X in PBS (PBSTx), and blocked in 10% heat- 
inactivated goat serum (GS) in PBSTx for 1 hour before incubation in 
primary antibody in 5% GS-PBSTx overnight at 4°C. Antibodies were: 
rabbit anti–DAB-1 (1:150; Sigma-Aldrich, D1569), rabbit anti–Purkin-
je cell protein 2 (anti-PCP2) (1:200; gift from Brad Denker, Harvard 
University, Boston, Massachusetts, USA), mouse anti-BrdU (1:100; 
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ATAC-Seq libraries were produced as previously described (44). Library 
quality was assessed on a 2100 Bioanalyzer and quantified using the 
KAPA library quantification kit (Kapa Biosystems). Six libraries were 
multiplexed (3 per genotype) and 75 bp paired-end reads were sequenced 
on a HiSeq4000 (Wellcome Trust Centre for Human Genetics, Oxford, 
United Kingdom). Reads were uniquely aligned to the mouse reference 
genome (mm10) using Bowtie (version 1.1.1) (66) with a maximum insert 
size for valid paired-end alignments of 2,000 and a maximum number 
of attempts of 200 to match an alignment for 1 mate with an alignment 
for the opposite mate. Peaks were called in 3 control replicates by com-
paring them to 3 cko samples and vice versa using MultiGPS (version 0.5) 
(67) with the minimum q value for reported peaks set at 0.05 and the 
mitochondrial genome excluded. The bedtools window function from 
BEDTools (version 2.17.0) (68) was used to identify ATAC-Seq peaks 
within 1,000 bp of differentially expressed genes (DEGs). 
DNase-Seq. Raw reads were obtained from Frank et al. (45), and 
analyzed in the same way as the ATAC-Seq reads, except in the map-
ping step, where reads mapping with up to 4 locations were retained 
for further analysis.
Heatmaps. Reads that fell within ±500 bp of all changed ATAC-
Seq peaks were plotted with ngs.plot.r (69), and regions were clus-
tered according to the peak value of the first profile, using a global 
color scale across all plots.
Behavioral tests. Three batches of mice were used for testing of 
developmental milestones, recording of ultrasonic vocalizations, and 
testing of juvenile-adult behavior. For the juvenile-adult behavior, 
tests were carried out in the following order: juvenile social investi-
gation, rotarod, open field, light/dark test, adult social investigation, 
3-chamber social approach, marble burying, olfactory habituation/
dishabituation, Morris water maze, and grip strength.
Using a battery of tests (70, 71), key behavioral milestones 
observed in mice prior to weaning (P2–P20) were used to assess core 
trajectories in the development of motor and sensory abilities (70) (see 
Supplemental Methods for detailed information). Ultrasonic vocaliza-
tions were recorded in pups across 3-minute sessions in response to 
social separation from the mother and siblings at P2, P4, P6, P8, and 
P12, in a dimly lit (<10 lux) soundproof chamber. The mean number 
of calls was used as a quantitative measure of communicative ability, 
as described previously (72). Motor coordination and learning were 
assessed on a rotating rod (Ugo Basile) as described previously (73) 
when the mice reached 42–45 days of age. The latency to fall for any 
particular day was calculated as the mean of 2 trials. Repetitive dig-
ging behavior to bury marbles was measured (74) in a dimly lit test 
room (<10 lux). Twelve blue glass marbles were arranged in a sym-
metrical 4-by-3-cm grid on top of 5-cm-deep sawdust (Litaspen pre-
mium, Datesand Ltd.) in a clean, standard housing cage (32 × 16 × 14 
cm). Each mouse was given 30 minutes to freely explore the cage, and 
the number of marbles buried was counted. Social investigation was 
assessed at different ages to evaluate trajectories across developmen-
tal stages from juvenile to adulthood (33, 75, 76). Social investigation 
of age-matched C57BL/6J sex-matched conspecifics was assessed in 
juvenile test mice (P21) as described previously (75). Social investiga-
tion of juvenile C57BL/6J sex-matched conspecifics was assessed in 
adult test mice as described previously (76).
Statistics. Statistical tests used are reported in the figure leg-
ends, where all data presented indicate mean ± SEM, unless other-
wise specified. A P value less than 0.05 was considered significant. 
Precision qPCR master mix with SYBR Green (Primerdesign Ltd.). All 
reactions were run in triplicate, and first-strand DNA synthesis reac-
tions without reverse transcriptase were used as controls. The quantifi-
cation cycle (Cq) threshold values were normalized to the housekeeping 
gene Gapdh to calculate the ΔCq value and the ΔΔCq calculated rela-
tive to the control sample. The primer sequences were: Chd7 forward 
5′-TCACCAGCCTTGGGCACAACTC-3′, reverse 5′-TAGCTGAGC-
GTTCTGTGCGCTG-3′; Reln forward 5′-TTACTCGCACCTTGCT-
GAAAT-3′, reverse 5′-CAGTTGCTGGTAGGAGTCAAAG-3′; Gapdh 
forward 5′-AGGTCGGTGTGAACGGATTTG-3′, reverse 5′-TGTAGAC-
CATGTAGTTGAGGTCA-3′.
RNA-Seq. GCps were purified from P7 control (Chd7fl/+) and cko 
(Math1-Cre Chd7fl/fl) mice as described above. Total RNA was extract-
ed from freshly isolated cells (5 × 106 per cerebellum) with an Agilent 
Absolutely RNA miniprep kit (Agilent Technologies). RNA quality and 
integrity were assessed on a 2100 Bioanalyzer and 2200 Tapestation 
using an R6K screenTape (Agilent Technologies). After quantifica-
tion on Qubit using Quant-iT RNA assay kit (Life Technologies), 2 μg 
total RNA was used from each sample for library preparation using an 
Illumina TruSeq kit. Libraries were resolved by agarose gel electro-
phoresis, and 250- to 550-bp DNA fragments were isolated and gel- 
purified with a Qiagen DNA gel extraction kit (Qiagen). Two librar-
ies with unique barcodes were combined and sequenced per lane on 
a HiSeq2000 (Illumina) at the Biomedical Research Centre, King’s 
Health Partners (London, United Kingdom). RNA-Seq reads were 
aligned to the mouse reference genome (mm10) using TopHat (ver-
sion 2.0.14) (61) with an expected inner distance between mate pairs 
of 150 bp and SD for the distribution on inner distances between 
mate pairs of 50 bp. The transcriptome index was created using 
Ensembl build 75. HTseq (version 0.6.1p1) (62) was used to estimate 
the number of reads (ftp://ftp.ensembl.org/pub/release-75/gtf/mus_ 
musculus/). An intersection-strict mode was used and all reads with 
an alignment quality lower than 3 skipped. Differential expression 
was analyzed with DESeq2 1.8.1. (https://bioconductor.org/packages/
release/bioc/html/DESeq2.html). Genes with an FDR less than 0.05 
were considered differentially expressed. RNA-Seq, ChIP-Seq, and 
ATAC-Seq data have been deposited in the NCBI’s Gene Expression 
Omnibus (GEO 18162240).
ChIP-Seq. GCps were purified from P7 control (Chd7fl/+) mice as 
described above. Freshly isolated cells (2 × 107 to 3 × 107) of each genotype 
were fixed, chromatin isolated, and precipitated with an antibody against 
H3K4me1 (Abcam ab8895), and ChIP-Seq libraries were produced and 
sequenced as previously described (63). The ChIP DNA libraries were 
sequenced (50 bp, single-end) on an Illumina HiSeq 2000 sequencer at 
the New York University Genome Technology Center (New York, New 
York, USA). The reads were aligned to the mouse reference genome 
(mm10) using Bowtie (version 1.1.0), allowing only uniquely mapping 
reads, with an insert size of 1,000 bases. Default values were used for 
all other parameters. Following mapping, PCR duplicates were removed 
using the SAMtools “rmdup” command (64). Identification of enriched 
regions was performed by comparison of the ChIP to the input reads 
using MACS2 (2.1.0.20140616) (65), with a P value cutoff of 0.0001 and 
3,90 as the model building parameters. The bedGraph output generated 
by MACS2 was used to visualize the ChIP and input signals.
ATAC-Seq. GCps were purified from P7 mice as described above. 
Intact nuclei were isolated (EZ Prep Nuclear Isolation Kit, Sigma- 
Aldrich) from 50,000 freshly isolated GCps of each genotype, and 
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